9th Circ. Won't Revisit Key FCA Ruling Against Gilead
Gilead Sciences Inc. must face a whistleblower's multibillion-dollar False Claims Act suit after the Ninth Circuit said Wednesday that it wouldn't rehear the appeal en banc, despite pleas from Gilead that...To view the full article, register now.
Already a subscriber? Click here to view full article